DME

(redirected from Diabetic macular edema)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
AcronymDefinition
DMEDurable Medical Equipment
DMEDistance Measuring Equipment
DMEDiabetic Macular Edema
DMEDivision of Medical Education (various schools)
DMEDepartment of Minerals and Energy
DMEDepartment of Medicine for the Elderly (UK)
DMEDistributed Management Environment
DMEDirect Memory Execution
DMEDigital Media Encoder
DMEDigital Media Edition
DMEDictation Macro Editor
DMEDictionary Module Editor
DMEDynamic Multiple Sector Encoding
DMEDimethoxyethane
DMEDesign Management Europe
DMEDigital Motor Electronics
DMEDependent Malic Enzyme
DMEDigital Marketing Event
DMEDry Malt Extract
DMEDimethylether
DMEDistribution de Matériel Électrique (French: Electrical Equipment Distribution; Luxembourg)
DMEDesign Management Education
DMEDubai Mercantile Exchange Limited
DMEDiploma in Mechanical Engineering
DMEDakota Minnesota & Eastern (railroad)
DMEDried Malt Extract
DMEDigital Media Edition (Microsoft)
DMEDiatomaceous Earth
DMEDistribution de Matériel Européen (French: European Equipment Distribution)
DMEDepartment of Medical Education (Armed Forces Institute of Pathology)
DMEDigital Music Entertainment (software)
DMEDecision Making Exercise
DMEDropping Mercury Electrode
DMEDrinking Made Easy (TV show)
DMEDirected Molecular Evolution (method)
DMEDoby's Mill Elementary School (Lugoff, SC; also seen as DMES)
DMEData Medium Exchange (SAP interface, bank transfers)
DMEDépannage Maintenance Électricité (French: Electrical Maintenance Troubleshooting)
DMEDeputy Managing Editor
DMEMoscow, Russia - Domodedovo (Airport Code)
DMEDigital Media Exchange, Inc. (Philippines)
DMEDevelopment, Modernization, and Enhancement
DMEDiploma in Metallurgy Engineering
DMEDell Media Experience
DMEDenis Mathez Entreprise (French construction company)
DMEDisturbance Monitoring Equipment (electrical grid operations)
DMEDirect Measurement Explorer
DMEDirect Machine Environment
DMEDeputy Medical Examiner
DMEDesignated Medical Examiner (US FAA)
DMEDynamic Modulus of Elasticity
DMEDialogue, Music & Effects (from audio post-production, a type of deliverable mix)
DMEDomestic Marijuana Eradication Program
DMEDirect Marketing Expense
DMEDmapedit (gaming map editor)
DMEDesign Margin Evaluation
DMEDrive Motor Electronics
DMEDirect Manufacturing Expense
DMEData Modulation Encoder
DMEDimier Marc Électricité (French electrical company)
DMEDesign Mission Effect
DMEDigital Mafia Enterprises, LLC
DMEDoctorate of Music Education
DMEDielectric Midgap Energy Model
DMEDirection-Biased Motion Estimation
References in periodicals archive ?
and followed them for 6-12 months; they concluded that even in cases with chronic diffuse diabetic macular edema, a long-term decrease of central retinal thickness and a gain in mean BCVA can be observed following repeated intravitreal injections of bevacizumab.
Prasad Eye Institute, Hyderabad, said, "Retinal diseases like age-related macular degeneration and diabetic macular edema are progressive conditions that can be managed effectively if diagnosed in a timely manner.
reported that in cases with chronic diffuse ischemic diabetic macular edema (a long-term decrease of central retinal thickness) can be observed following repeated intravitreal injections of bevacizumab, he also added that "treatment with bevacizumab at an earlier stage of diabetic macular edema without ischemia may be associated with an even better functional outcome".
Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab Arch Ophthalmol 2012;130:1153-1161.
Diabetic macular edema develops and progresses as a result of the interaction of different non-modifiable and modifiable risk factors.
Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome.
Intravitreal OZURDEX: Is it "The Magic Potion" for Diabetic Macular Edema — Dr Nishikant Borse
Glitazone use associated with diabetic macular edema.
19 mg is a sustained release intravitreal implant approved in the US to treat diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.
The report provides a snapshot of the global therapeutic landscape of Diabetic Macular Edema
In other developments at the company, Roche reported last month that Lucentis (ranibizumab injection) was approved by the Food and Drug Administration for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness.